%0 Journal Article
%T Randomised controlled trial begins for Ebola therapeutics.
%A Nakkazi E
%J Lancet
%V 392
%N 10162
%D 12 2018 1
%M 30527603
%F 202.731
%R 10.1016/S0140-6736(18)33011-3
%X